A phase II trial of oral tegafur and uracil plus cisplatin in patients with inoperable nonsmall cell lung cancer
Open Access
- 1 June 1995
- Vol. 75 (11) , 2677-2680
- https://doi.org/10.1002/1097-0142(19950601)75:11<2677::aid-cncr2820751106>3.0.co;2-d
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Toxicity Grading Criteria of the Japan Clinical Oncology GroupJapanese Journal of Clinical Oncology, 1993
- Association of interleukin-2 therapy with staphylococcal bacteremiaCancer, 1991
- Phase II trial of UFT in advanced colorectal and gastric cancerBritish Journal of Cancer, 1990
- Randomized study of continuous infusion fluorouracil versus fluorouracil plus cisplatin in patients with metastatic colorectal cancer.Journal of Clinical Oncology, 1990
- Fluorouracil: biochemistry and pharmacology.Journal of Clinical Oncology, 1988
- UFT Is More Antineoplastic against Gastric Carcinoma than 5-Fluorouracil, 1-(2-Tetrahydrofuryl)-5-fluorouracil and 1-Hexylcarbamoyl-5-FluorouracilChemotherapy, 1988
- Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells.Proceedings of the National Academy of Sciences, 1986
- A New International Staging System for Lung CancerChest, 1986
- Adjuvant chemotherapy with Cis-diamminodichloroplatinum II and 120-hour infusion 5-fluorouracil in stage III and IV squamous cell carcinoma of the head and neckCancer, 1983
- Clinical basis of chemotherapy for gastric cancer with uracil and 1-(2′-tetrahydrofuryl)-5-fluorouracilGastroenterologia Japonica, 1980